Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Feb;2(2):a009399.
doi: 10.1101/cshperspect.a009399.

α-Synuclein in Parkinson's disease

Leonidas Stefanis  1
Affiliations
Review

α-Synuclein in Parkinson's disease

Leonidas Stefanis. Cold Spring Harb Perspect Med. 2012 Feb.

Abstract

α-Synuclein is a presynaptic neuronal protein that is linked genetically and neuropathologically to Parkinson's disease (PD). α-Synuclein may contribute to PD pathogenesis in a number of ways, but it is generally thought that its aberrant soluble oligomeric conformations, termed protofibrils, are the toxic species that mediate disruption of cellular homeostasis and neuronal death, through effects on various intracellular targets, including synaptic function. Furthermore, secreted α-synuclein may exert deleterious effects on neighboring cells, including seeding of aggregation, thus possibly contributing to disease propagation. Although the extent to which α-synuclein is involved in all cases of PD is not clear, targeting the toxic functions conferred by this protein when it is dysregulated may lead to novel therapeutic strategies not only in PD, but also in other neurodegenerative conditions, termed synucleinopathies.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schemtic structure of α-synuclein.
Figure 2.
Figure 2.
Possible targets for therapeutic intervention in PD and related synucleinopathies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, et al. 2000. Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239–252 - PubMed
    1. Al-Chalabi A, Dürr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, et al. 2009. Genetic variants of the α-synuclein gene SNCA are associated with multiple system atrophy. PLoS One 4: e7114. - PMC - PubMed
    1. Alim MA, Hossain MS, Arima K, Takeda K, Izumiyama Y, Nakamura M, Kaji H, Shinoda T, Hisanaga S, Ueda K 2002. Tubulin seeds α-synuclein fibril formation. J Biol Chem 277: 2112–2117 - PubMed
    1. Alim MA, Ma QL, Takeda K, Aizawa T, Matsubara M, Nakamura M, Asada A, Saito T, Kaji H, Yoshii M, et al. 2004. Demonstration of a role for α-synuclein as a functional microtubule-associated protein. J Alzheimers Dis 6: 435–442 - PubMed
    1. Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH 2010. Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67: 1464–1472 - PubMed

Publication types